GlassScriptPhysician profile
Charles R Gray
NPI 1316970163
$1,184.72
in general payments reported to CMS, 2019-2025
17 companies · $656 in 2025
The $656 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $94.36 · 2023: $17.46 · 2024: $301 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $388.84 | 2021-2025 | Ozempic, Wegovy |
| Otsuka America Pharmaceutical, INC. | $117.60 | 2025 | Rexulti |
| Inspire Medical Systems, INC. | $84.94 | 2025 | Inspire |
| Pfizer INC. | $83.89 | 2024-2025 | |
| Amgen INC. | $80.45 | 2022 | |
| Philips North America LLC | $77.65 | 2024-2025 | (Ck7) Extended Holter, Extended Holter |
| Aimmune Therapeutics, INC. | $50.55 | 2025 | Zenpep |
| Astrazeneca Pharmaceuticals LP | $47.65 | 2024 | Farxiga |
| Hologic Sales and Service, LLC | $43.32 | 2024 | Thinprep 2000 Processor, Aptima |
| Shield Therapeutics INC | $41.69 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.98 | 2025 | Xifaxan |
| Seqirus USA INC | $33.46 | 2025 | Fluad, Flucelvax |
| Astellas Pharma US INC | $29.48 | 2024 | Veozah |
| Lilly USA, LLC | $19.02 | 2024 | Mounjaro |
| Exact Sciences Corporation | $18.83 | 2024 | Cologuard Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $17.46 | 2023 | Vivitrol |
| Abbvie INC. | $13.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.